Comorbidities in aging patients with sickle cell disease

Samir K Ballas1

  • 1Cardeza Foundation for Hematologic Research, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

Insights

Sickle cell disease (SCD) survival has improved, but aging patients now face comorbidities. This review identifies these conditions to ensure better long-term health outcomes for individuals with SCD.

Area of Science:

  • Hematology
  • Genetics
  • Internal Medicine

Background:

  • Sickle cell disease (SCD) is a complex genetic disorder with diverse molecular and clinical manifestations.
  • Acute complications include vaso-occlusive crises and acute chest syndrome, while chronic issues involve avascular necrosis and leg ulcers.
  • Therapeutic advances have significantly improved patient survival, leading to an aging SCD population.

Purpose of the Study:

  • To identify and characterize comorbidities in elderly patients with sickle cell disease.
  • To differentiate these comorbidities from the underlying SCD to guide appropriate management.
  • To inform strategies for maintaining improved survival and quality of life in aging SCD patients.

Main Methods:

  • This is a review article, synthesizing existing literature on SCD comorbidities in the elderly.
  • The review focuses on identifying conditions common in the aging general population that may be influenced by or co-occur with SCD.
  • Emphasis is placed on distinguishing primary SCD complications from age-related comorbidities.

Main Results:

  • Improved survival in SCD has introduced age-related comorbidities, posing a new challenge to patient management.
  • These comorbidities can potentially offset the gains in survival achieved through modern therapies.
  • Differentiating comorbidities from SCD is crucial for effective treatment planning.

Conclusions:

  • Aging individuals with SCD are experiencing comorbidities that require careful identification and management.
  • Proactive identification and differentiation of comorbidities are essential for sustaining improved survival rates in SCD.
  • Further research and clinical strategies are needed to address the complex health needs of the aging SCD population.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
265
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
259
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
801